Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
Open Access
- 1 April 2021
- journal article
- research article
- Published by Future Medicine Ltd in Future Virology
- Vol. 16 (4), 277-291
- https://doi.org/10.2217/fvl-2020-0342
Abstract
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we have studied the possible mechanism of action of ivermectin using in silico approaches. Materials & methods: Interaction of ivermectin against the key proteins involved in SARS-CoV-2 pathogenesis were investigated through molecular docking and molecular dynamic simulation. Results: Ivermectin was found as a blocker of viral replicase, protease and human TMPRSS2, which could be the biophysical basis behind its antiviral efficiency. The antiviral action and ADMET profile of ivermectin was on par with the currently used anticorona drugs such as hydroxychloroquine and remdesivir. Conclusion: Our study enlightens the candidature of ivermectin as an effective drug for treating COVID-19.Keywords
This publication has 33 references indexed in Scilit:
- Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS CoronavirusJournal of Virology, 2020
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus EntryJournal of Virology, 2020
- Safety of oral ivermectin during pregnancy: a systematic review and meta-analysisThe Lancet. Global Health, 2019
- Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conferenceAntiviral Research, 2019
- Ivermectin – Old Drug, New Tricks?Trends in Parasitology, 2017
- Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular PerspectivesCurrent Drug Metabolism, 2016
- Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian FilariasisClinical Infectious Diseases, 2015
- iMODS: internal coordinates normal mode analysis serverNucleic Acids Research, 2014
- Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for eliminationMalaria Journal, 2013
- Quality Assessment of Protein Structure ModelsCurrent Protein & Peptide Science, 2009